The clinical trial data is specifically reassuring on this point: across six trials involving approximately 900 participants, glucose levels, insulin levels, and markers of insulin sensitivity remained unchanged from baseline
Neuroproteccin: Se han observado efectos protectores en modelos de traumatismo craneoenceflico, isquemia cerebral y lesin de la mdula espinal
Focus on these factors instead: Quality of the peptide (purity, proper storage, legitimate sourcing) Consistency of dosing (daily administration at similar times) Route of administration (subcutaneous is most common and effective for most uses) Adequate dosage (underdosing is more common than overdosing) Supporting recovery factors (sleep, nutrition, stress management) Ive seen people get lackluster results from improperly prepared peptides dosed perfectly, and exceptional results from high-quality BPC-157 dosed once daily
, ,
Currently, publicly available research on Dihexa peptide powder is primarily focused on animal models (e.g., rat models of Alzheimer's disease and traumatic brain injury), along with a very limited number of human anecdotal reports
